N19 polyepitope as a carrier for enhanced immunogenicity and protective efficacy of meningococcal conjugate vaccines

被引：23
|
作者：
Baraldo, K
Mori, E
Bartoloni, A
Petracca, R
Giannozzi, A
Norelli, F
Rappuoli, R
Grandi, G
Del Giudice, G
机构：
[1] Chiron Vaccines, Res Ctr, I-53100 Siena, Italy
[2] Chiron Vaccines, Technol Dev, I-53100 Siena, Italy
来源：
INFECTION AND IMMUNITY | 2004年 / 72卷 / 08期
关键词：
D O I：
10.1128/IAI.72.8.4884-4887.2004
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
N19, a string of human universal CD4 T-cell epitopes from various pathogen-derived antigens, was shown to exert a stronger carrier effect than CRM197 for the induction of anti-group C Neisseria meningitidis capsular polysaccharide (MenC), after immunization of mice with various dosages of N19-MenC or CRM-MenC conjugate vaccines. After two immunizations, the N19-based construct induced anti-MenC antibody and protective bactericidal antibody titers higher than those induced by three doses of the CRM-MenC conjugate and required lower amounts of conjugate. N19-based conjugates are superior to CRM-based conjugates to induce protective immune responses to MenC conjugates.
引用
收藏
页码：4884 / 4887
页数：4
相关论文
共 50 条
  • [31] Interchangeability of meningococcal group C conjugate vaccines with different carrier proteins in the United Kingdom infant immunisation schedule
    Ladhani, Shamez N.
    Andrews, Nick J.
    Waight, Pauline
    Hallis, Bassam
    Matheson, Mary
    England, Anna
    Findlow, Helen
    Bai, Xilian
    Borrow, Ray
    Burbidge, Polly
    Pearce, Emma
    Goldblatt, David
    Miller, Elizabeth
    VACCINE, 2015, 33 (05) : 648 - 655
  • [32] Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection
    Burrage, M
    Robinson, A
    Borrow, R
    Andrews, N
    Southern, J
    Findlow, J
    Martin, S
    Thornton, C
    Goldblatt, D
    Corbel, M
    Sesardic, D
    Cartwight, K
    Richmond, P
    Miller, E
    INFECTION AND IMMUNITY, 2002, 70 (09) : 4946 - 4954
  • [33] Vaxfectin™ enhances immunogenicity and protective efficacy of P-yoelii circumsporozoite DNA vaccines
    Sedegah, M
    Rogers, WO
    Belmonte, A
    Belmonte, M
    Banania, G
    Patterson, N
    Ferrari, M
    Kaslow, DC
    Carucci, CJ
    Richie, TL
    Doolan, DL
    VACCINE, 2006, 24 (11) : 1921 - 1927
  • [34] Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors
    Tanghe, A
    Lefèvre, P
    Denis, O
    D'Souza, S
    Braibant, M
    Lozes, E
    Singh, M
    Montgomery, D
    Content, J
    Huygen, K
    JOURNAL OF IMMUNOLOGY, 1999, 162 (02): : 1113 - 1119
  • [35] Influences of glycosylation on antigenicity, immunogenicity, and protective efficacy of Ebola virus GP DNA vaccines
    Dowling, William
    Thompson, Elizabeth
    Badger, Catherine
    Mellquist, Jenny L.
    Garrison, Aura R.
    Smith, Jeffery M.
    Paragas, Jason
    Hogan, Robert J.
    Schmaljohn, Connie
    JOURNAL OF VIROLOGY, 2007, 81 (04) : 1821 - 1837
  • [36] Preclinical immunogenicity and functional activity studies of an A plus W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines
    Tunheima, G.
    Arnemo, M.
    Naess, L. M.
    Fjeldheim, A. K.
    Nome, L.
    Bolstad, K.
    Aase, A.
    Mandiarote, A.
    Gonzalez, H.
    Gonzalez, D.
    Garcia, L.
    Cardoso, D.
    Norheim, G.
    Rosenqvist, E.
    VACCINE, 2013, 31 (51) : 6097 - 6106
  • [37] An animal model to evaluate the protective efficacy ofHaemophilus influenzae type b conjugate vaccines
    Hyun Sung Kim
    Tae Hyeon Yoo
    Yang Suk Jang
    Hun Kim
    Jin Yong Park
    Byung-Ki Hur
    Yeon-Woo Ryu
    Jong Su Kim
    Biotechnology and Bioprocess Engineering, 2004, 9 : 490 - 494
  • [38] PROTECTIVE EFFICACY OF CONJUGATE VACCINES AGAINST EXPERIMENTAL CHALLENGE WITH PORCINE ACTINOBACILLUS-PLEUROPNEUMONIAE
    BYRD, W
    HARMON, BG
    KADIS, S
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 34 (3-4) : 307 - 324
  • [39] An animal model to evaluate the protective efficacy of Haemophilus influenzae type b conjugate vaccines
    Kim, HS
    Yoo, TH
    Jang, YS
    Kim, H
    Park, JY
    Hur, BK
    Ryu, YW
    Kim, JS
    BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, 2004, 9 (06) : 490 - 494
  • [40] A novel combined conjugate vaccine: Enhanced immunogenicity of bFGF with CRM197 as a carrier protein
    Zhang, Hai-Long
    Yuan, Chuang
    Zhang, Dong-Mei
    Shi, Hua-Shan
    Li, Meng
    Luo, Zi-Chao
    Wan, Yang
    Lu, Lian
    Luo, Shun-Tao
    Yang, Li
    MOLECULAR MEDICINE REPORTS, 2011, 4 (05) : 857 - 863
12345